- Home
- DLNG vs FBRX Comparison
DLNG vs FBRX Comparison
Compare DLNG & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLNG
- FBRX
- Stock Information
- Founded
- DLNG 2013
- FBRX N/A
- Country
- DLNG Greece
- FBRX United States
- Employees
- DLNG N/A
- FBRX N/A
- Industry
- DLNG Marine Transportation
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- DLNG Consumer Discretionary
- FBRX Health Care
- Exchange
- DLNG Nasdaq
- FBRX Nasdaq
- Market Cap
- DLNG 131.9M
- FBRX 154.5M
- IPO Year
- DLNG 2013
- FBRX N/A
- Fundamental
- Price
- DLNG N/A
- FBRX $14.37
- Analyst Decision
- DLNG
- FBRX Strong Buy
- Analyst Count
- DLNG 0
- FBRX 3
- Target Price
- DLNG N/A
- FBRX $68.00
- AVG Volume (30 Days)
- DLNG 42.9K
- FBRX 103.4K
- Earning Date
- DLNG 11-21-2025
- FBRX 11-13-2025
- Dividend Yield
- DLNG 5.57%
- FBRX N/A
- EPS Growth
- DLNG 90.14
- FBRX N/A
- EPS
- DLNG 1.14
- FBRX N/A
- Revenue
- DLNG $158,453,000.00
- FBRX N/A
- Revenue This Year
- DLNG N/A
- FBRX N/A
- Revenue Next Year
- DLNG $0.37
- FBRX N/A
- P/E Ratio
- DLNG $3.04
- FBRX N/A
- Revenue Growth
- DLNG N/A
- FBRX N/A
- 52 Week Low
- DLNG $3.18
- FBRX $4.11
- 52 Week High
- DLNG $5.65
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- DLNG N/A
- FBRX 57.28
- Support Level
- DLNG N/A
- FBRX $13.90
- Resistance Level
- DLNG N/A
- FBRX $15.49
- Average True Range (ATR)
- DLNG 0.00
- FBRX 1.39
- MACD
- DLNG 0.00
- FBRX -0.04
- Stochastic Oscillator
- DLNG 0.00
- FBRX 46.66
About DLNG Dynagas LNG Partners LP Common Units
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).